Personalized Dosimetry With Y-90 Glass Microspheres Shows Positive Activity in HCC
Etienne Garin, MD, PhD, details how the PROACTIF study was conducted and how Y-90 Glass Microspheres could fill an unmet need for patients with hepatocellular carcinoma.